|
SYNJ2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.95143999999203E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.205100E-04 |
| Normal-vs-Stage2 |
2.07929999995748E-06 |
| Normal-vs-Stage3 |
6.20369999999593E-05 |
| Normal-vs-Stage4 |
6.603000E-03 |
| Stage1-vs-Stage2 |
5.060500E-03 |
| Stage1-vs-Stage3 |
9.112400E-02 |
| Stage1-vs-Stage4 |
5.476800E-01 |
| Stage2-vs-Stage3 |
1.367580E-01 |
| Stage2-vs-Stage4 |
1.772410E-01 |
| Stage3-vs-Stage4 |
7.184800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51509999999355E-05 |
| Normal-vs-AfricanAmerican |
3.996500E-02 |
| Normal-vs-Asian |
1.405050E-01 |
| Caucasian-vs-AfricanAmerican |
4.601800E-01 |
| Caucasian-vs-Asian |
9.188200E-01 |
| AfricanAmerican-vs-Asian |
7.200400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.72430000000246E-05 |
| Normal-vs-Female |
1.518490E-03 |
| Male-vs-Female |
5.758800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.488000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.783900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.61737999999634E-05 |
| Normal-vs-Age(81-100Yrs) |
7.53460000000317E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.673380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.943800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.083800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.931690E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.083780E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.240000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.704800E-01 |
| Normal-vs-Grade 2 |
1.755750E-03 |
| Normal-vs-Grade 3 |
1.37469999994533E-06 |
| Normal-vs-Grade 4 |
2.755700E-04 |
| Grade 1-vs-Grade 2 |
1.243420E-01 |
| Grade 1-vs-Grade 3 |
1.681840E-02 |
| Grade 1-vs-Grade 4 |
3.106500E-02 |
| Grade 2-vs-Grade 3 |
2.216300E-02 |
| Grade 2-vs-Grade 4 |
1.521630E-01 |
| Grade 3-vs-Grade 4 |
8.224600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.023350E-04 |
| Normal-vs-ccB subtype |
2.558100E-03 |
| ccA subtype-vs-ccB subtype |
1.742020E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1237999999979E-05 |
| Normal-vs-N1 |
3.658400E-02 |
| N0-vs-N1 |
8.322400E-01 |
|
|
